Clinical Pathways GPS

For professionals creating a clinical pathway for a disease state, it is important to understand the various stakeholder biases in real-world contexts, so that appropriate prompts may be integrated into the pathway in order to achieve the best outcomes.
Clinical pathways have begun including financial and accountable outcome measures. As we go into 2018, these issues are expected to undergo major changes as a result of legislation and regulations coming out of Washington.
As a retail provider, CVS not only has its pharmacies, which have prescribing authority in several states and can act as treatment providers in certain areas, such as vaccination. It also has the ability to operate clinics in many locations.
As organizations new to pathways look to develop their processes, it is highly beneficial to examine the foundations used by leaders within each therapeutic area of interest.
Using clinical pathways to direct exactly where and when care can be best provided is critical to population health management success.
For clinical pathways to be most effective, they need to accommodate many external factors impacting patients.
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the FDA has ushered in a new direction for the government agency, which is likely to alter the availability and use of pharmaceuticals in the United States.
Should the Trump administration succeed in rolling back many ACA key policies, clinical pathways will need to mitigate the costs from patients, providers and payers.
The preparatory precautions detailed in this column serve to raise awareness of the specific needs to older adults during travel.
Clinical pathways that allow for differences in patient goals and preferences will be better positioned to achieve the Triple Aim.